Breaking News Instant updates and real-time market news.

ALK

Alaska Air

$61.57

1.75 (2.93%)

05:12
10/15/18
10/15
05:12
10/15/18
05:12

Alaska Air deserves premium valuation, says Imperial Capital

Imperial Capital analyst Michael Derchin says Alaska Air Group deserves a premium valuation given its "strong likelihood" of industry leading unit growth in fiscal 2019. In its investor update on Friday, Alaska Air indicated Q3 RASM is now likely to be flattish, the higher end of its flat to down 2% guidance, due to better than expected close-in fares, Derchin tells investors in a research note. He believes the "heavy lifting" of merger integration is now largely in the rear-view mirror and keeps an Outperform rating on Alaska Air with a $95 price target.

  • 25

    Oct

  • 27

    Nov

ALK Alaska Air
$61.57

1.75 (2.93%)

10/09/18
WOLF
10/09/18
DOWNGRADE
WOLF
Peer Perform
Alaska Air downgraded to Peer Perform from Outperform at Wolfe Research
09/27/18
09/27/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Jernigan Capital (JCAP) upgraded to Buy from Hold at Jefferies with analyst George Hoglund saying he has an increasing near-term opportunity to acquire as many as 20 recently completed self-storage facilities in lease-up over the next 12-18 months. 2. Alaska Air (ALK) upgraded to Outperform from In-Line at Imperial Capital with analyst Michael Derchin saying the shares warrant a premium valuation due to the likelihood of industry-leading unit revenue growth in fiscal 2019. 3. Cameco (CCJ) upgraded to Outperform from Market Perform at Raymond James with analyst Alexander Pearce citing the latest decision by the Tax Court of Canada in favor of the company in regards to its dispute of the reassessments ordered by Canada Revenue Agency. 4. CarMax (KMX) upgraded to Outperform from Neutral at Baird. 5. KB Home (KBH) upgraded to Outperform from Market Perform at Raymond James. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/27/18
IMPC
09/27/18
UPGRADE
Target $95
IMPC
Outperform
Alaska Air upgraded to Outperform from In-Line at Imperial Capital
Imperial Capital analyst Michael Derchin upgraded Alaska Air Group to Outperform and raised his price target for the shares to $95 from $62. The shares warrant a premium valuation due to the likelihood of industry-leading unit revenue growth in fiscal 2019, Derchin tells investors in a research note. Further, he believes the "heavy lifting" of merger integration is largely in the rear-view mirror. He estimates Alaska Air leads the industry in fiscal 2019 unit revenue growth at 4%.
07/30/18
07/30/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Colgate-Palmolive (CL) downgraded to Neutral from Outperform at Macquarie with analyst Caroline Levy saying she does not expect growth to accelerate over the next several quarters and lowered her FY18 organic sales estimate to 0.5% from 1% and FY19 to 2.2% from 3.2%. 2. Alaska Air (ALK) downgraded to Neutral from Outperform at Macquarie. 3. Perrigo (PRGO) downgraded to Hold from Buy at Argus with analyst Jasper Hellweg citing the challenges faced by the company around the "industry-wide price erosion, a legal investigation, and a reduction in FDA approvals." 4. Synchronoss (SNCR) downgraded to Sell from Hold at Stifel with analyst Tom Roderick saying recent filings reveal that liquidity issues loom, the company is "out of levers, and time is not on their side." 5. Synchrony (SYF) downgraded to Equal Weight from Overweight at Barclays with analyst Mark Devries saying the loss of the Walmart (WMT) credit card business heightens contract renewal risk and caps upside in the stock. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

RYTM

Rhythm Pharmaceuticals

$20.90

0.52 (2.55%)

06:24
10/16/19
10/16
06:24
10/16/19
06:24
Syndicate
Rhythm Pharmaceuticals 8.11M share Spot Secondary priced at $18.50 »

The deal priced inside…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

PRQR

ProQR Therapeutics

$6.21

-0.09 (-1.43%)

06:23
10/16/19
10/16
06:23
10/16/19
06:23
Syndicate
ProQR Therapeutics 9.091M share Spot Secondary priced at $5.50 »

Citi and Evercore ISI…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

SSNLF

Samsung

$0.00

(0.00%)

06:23
10/16/19
10/16
06:23
10/16/19
06:23
Periodicals
Samsung places further EUV equipment orders, DigiTimes reports »

Samsung Electronics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

RYTM

Rhythm Pharmaceuticals

$20.90

0.52 (2.55%)

06:23
10/16/19
10/16
06:23
10/16/19
06:23
Syndicate
Rhythm Pharmaceuticals 8.108M share Spot Secondary priced at $18.50 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

PRNB

Principia Biopharma

$29.88

0.7 (2.40%)

06:22
10/16/19
10/16
06:22
10/16/19
06:22
Syndicate
Principia Biopharma 7.5M share Spot Secondary priced at $28.00 »

The deal priced inside…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

EURN

Euronav NV

$10.72

-0.605 (-5.34%)

06:21
10/16/19
10/16
06:21
10/16/19
06:21
Recommendations
Euronav NV analyst commentary  »

Euronav a good play on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

BA

Boeing

$370.99

-2.05 (-0.55%)

, EADSY

Airbus

$0.00

(0.00%)

06:20
10/16/19
10/16
06:20
10/16/19
06:20
Periodicals
Entry date for Boeing's 777-8 depending on customer demand, Reuters reports »

The date of entry into…

BA

Boeing

$370.99

-2.05 (-0.55%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

XOG

Extraction Oil & Gas

$2.65

-0.05 (-1.85%)

06:19
10/16/19
10/16
06:19
10/16/19
06:19
Downgrade
Extraction Oil & Gas rating change  »

Extraction Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

CNI

Canadian National

$86.78

0.38 (0.44%)

06:19
10/16/19
10/16
06:19
10/16/19
06:19
Upgrade
Canadian National rating change  »

Canadian National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

  • 21

    Nov

  • 22

    Nov

INOV

Inovalon

$15.04

0.2 (1.35%)

06:19
10/16/19
10/16
06:19
10/16/19
06:19
Initiation
Inovalon initiated  »

Citi starts Inovalon with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAB

Wabtec

$67.83

1.185 (1.78%)

06:17
10/16/19
10/16
06:17
10/16/19
06:17
Initiation
Wabtec initiated  »

Wabtec initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 13

    Nov

ADBE

Adobe

$279.40

1.61 (0.58%)

06:15
10/16/19
10/16
06:15
10/16/19
06:15
Downgrade
Adobe rating change  »

Citi downgrades Adobe to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

  • 29

    Oct

  • 04

    Nov

PLMR

Palomar

$40.61

-0.26 (-0.64%)

06:13
10/16/19
10/16
06:13
10/16/19
06:13
Initiation
Palomar initiated  »

Palomar initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXSM

Axsome Therapeutics

$20.65

2.42 (13.27%)

06:12
10/16/19
10/16
06:12
10/16/19
06:12
Initiation
Axsome Therapeutics initiated  »

Axsome Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNBR

Sleep Number

$46.69

0.48 (1.04%)

06:11
10/16/19
10/16
06:11
10/16/19
06:11
Recommendations
Sleep Number analyst commentary  »

Sleep Number price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNI

Canadian National

$86.78

0.38 (0.44%)

06:11
10/16/19
10/16
06:11
10/16/19
06:11
Upgrade
Canadian National rating change  »

Canadian National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

  • 21

    Nov

  • 22

    Nov

PLMR

Palomar

$40.61

-0.26 (-0.64%)

06:10
10/16/19
10/16
06:10
10/16/19
06:10
Initiation
Palomar initiated  »

Palomar initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CP

Canadian Pacific

$218.42

3.27 (1.52%)

06:08
10/16/19
10/16
06:08
10/16/19
06:08
Downgrade
Canadian Pacific rating change  »

Canadian Pacific…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

MCK

McKesson

$138.17

4.01 (2.99%)

, ABC

AmerisourceBergen

$83.18

1.6 (1.96%)

06:08
10/16/19
10/16
06:08
10/16/19
06:08
Recommendations
McKesson, AmerisourceBergen, Cardinal Health analyst commentary  »

Barclays ups McKesson…

MCK

McKesson

$138.17

4.01 (2.99%)

ABC

AmerisourceBergen

$83.18

1.6 (1.96%)

CAH

Cardinal Health

$47.93

1.16 (2.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 07

    Nov

I

Intelsat

$26.09

1.09 (4.36%)

06:05
10/16/19
10/16
06:05
10/16/19
06:05
Hot Stocks
Intelsat and Marlink extend partnership for maritime broadband services »

Intelsat and Marlink have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOMX

Foamix

$3.00

0.145 (5.09%)

06:03
10/16/19
10/16
06:03
10/16/19
06:03
Recommendations
Foamix analyst commentary  »

Barclays likes Foamix…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 20

    Oct

TWTR

Twitter

$40.26

0.5 (1.26%)

06:03
10/16/19
10/16
06:03
10/16/19
06:03
Hot Stocks
Twitter clarifies when it will enforce rules against world leaders »

Twitter said in a blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

MOH

Molina Healthcare

$117.37

4.885 (4.34%)

06:02
10/16/19
10/16
06:02
10/16/19
06:02
Hot Stocks
Molina Healthcare to acquire certain assets of YourCare Health Plan for $40M »

Molina Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

FBM

Foundation Building Materials

$17.55

0.11 (0.63%)

06:01
10/16/19
10/16
06:01
10/16/19
06:01
Upgrade
Foundation Building Materials rating change  »

Foundation Building…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBSH

Commerce Bancshares

$60.24

0.87 (1.47%)

06:00
10/16/19
10/16
06:00
10/16/19
06:00
Earnings
Commerce Bancshares reports Q3 EPS 98c, consensus 92c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.